Nanoscale Discoveries to Transform Clinical Outcomes

Cancer nanotechnology is the engineering of nanoscale materials that aim to revolutionize the diagnosis, treatment, prevention, and study of cancer. Since its inception, cancer nanotechnology research has produced multiple diagnostics and therapies that are making an impact on patients. The 2025 Cancer Nanotechnology GRC will discuss current efforts to produce personalized nanomedicines, immunotherapeutic nanoparticles, diagnostic imaging and sensing platforms, and research tools, to further improve patient outcomes. The 2025 Cancer Nanotechnology GRC, and the associated trainee-focused GRS, will bring together exceptional scientists and clinicians to: 1) share cutting-edge research in cancer nanotechnology; 2) foster discussion, exchange of ideas, and promote collaborations in a collegial and supportive environment, and; 3) enhance the training and development of young scientists while also promoting diversity and inclusion.